Rustum YM - Search Results

1

Predictive tests for cancer chemotherapy and the problem of tumor cell heterogeneity.

Rustum YM, Slocum HK. Rustum YM, et al. Prog Clin Biol Res. 1988;276:119-37. Prog Clin Biol Res. 1988. PMID: 3051019 Review. No abstract available.

2

Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.

Raymakers RA, Slocum HK, Minderman H, Malmberg M, Rustum YM. Raymakers RA, et al. Among authors: rustum ym. Exp Hematol. 1993 May;21(5):602-7. Exp Hematol. 1993. PMID: 8513859

3

In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.

Seraphim LA, Perrapato SD, Slocum HK, Rustum YM, Huben RP. Seraphim LA, et al. Among authors: rustum ym. J Urol. 1991 Mar;145(3):613-7. doi: 10.1016/s0022-5347(17)38406-9. J Urol. 1991. PMID: 1900087

4

Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts.

Azrak RG, Cao S, Slocum HK, Tóth K, Durrani FA, Yin MB, Pendyala L, Zhang W, McLeod HL, Rustum YM. Azrak RG, et al. Among authors: rustum ym. Clin Cancer Res. 2004 Feb 1;10(3):1121-9. doi: 10.1158/1078-0432.ccr-0913-3. Clin Cancer Res. 2004. PMID: 14871992

5

Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy.

Bhattacharya A, Tóth K, Mazurchuk R, Spernyak JA, Slocum HK, Pendyala L, Azrak R, Cao S, Durrani FA, Rustum YM. Bhattacharya A, et al. Among authors: rustum ym. Clin Cancer Res. 2004 Dec 1;10(23):8005-17. doi: 10.1158/1078-0432.CCR-04-1306. Clin Cancer Res. 2004. PMID: 15585636

6

Image analysis using the fluorochromasia assay to quantify tumor drug sensitivity.

Gibbs JF, Rustum YM, Slocum HK. Gibbs JF, et al. Among authors: rustum ym. Methods Mol Med. 2005;110:185-95. doi: 10.1385/1-59259-869-2:185. Methods Mol Med. 2005. PMID: 15901936

7

Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.

Bhattacharya A, Tóth K, Durrani FA, Cao S, Slocum HK, Chintala S, Rustum YM. Bhattacharya A, et al. Among authors: rustum ym. Neoplasia. 2008 Aug;10(8):857-65. doi: 10.1593/neo.08424. Neoplasia. 2008. PMID: 18670644 Free PMC article.

8

Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts.

Chintala S, Tóth K, Yin MB, Bhattacharya A, Smith SB, Ola MS, Cao S, Durrani FA, Zinia TR, Dean R, Slocum HK, Rustum YM. Chintala S, et al. Among authors: rustum ym. Chemotherapy. 2010;56(3):223-33. doi: 10.1159/000316334. Epub 2010 Jun 11. Chemotherapy. 2010. PMID: 20551639 Free PMC article.

9

Assessment of human genitourinary tumors and chemosensitivity testing in 3-dimensional collagen gel culture.

Perrapato SD, Slocum HK, Huben RP, Ghosh R, Rustum Y. Perrapato SD, et al. J Urol. 1990 May;143(5):1041-5. doi: 10.1016/s0022-5347(17)40179-0. J Urol. 1990. PMID: 2329594

10

Determinants of Ara-C action: biochemical consideration.

Rustum YM, Slocum HK, Li ZR. Rustum YM, et al. Prog Clin Biol Res. 1983;132E:107-20. Prog Clin Biol Res. 1983. PMID: 6689076 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters